Anaplastic thyroid cancer (ATC) is a rare but highly aggressive kind of thyroid cancer.
Various therapeutic methods have been considered for the treatment of ATC, but its …

Well-differentiated thyroid carcinoma has a favorable prognosis with a 5-year survival rate of
over 95%. However, the undifferentiated or anaplastic type accounting for< 0.2%, usually in …

Background Emerging evidence suggests that secreted phosphoprotein 1 (SPP1) is
involved in tumor cell progression in multiple cancer types. However, the role of SPP1 in …

Simple Summary Anaplastic thyroid carcinoma (ATC) is a tumor with exceedingly high
mortality rates, and current treatment options are very limited once the disease has spread …

Glioma-associated oncogene (Gli) antagonist-61 (GANT61) not only suppresses the
malignant behavior of several cancers but also presents synergistic effects with other …

Simple Summary In the last decades, many researchers produced promising data
concerning genetics and tumor microenvironment of poorly differentiated thyroid cancer …

Rationale: The blood-brain barrier (BBB) is a major obstacle for drug delivery to the brain.
Sonopermeation, which relies on the combination of ultrasound and microbubbles, has …

N6-methyladenosine (m6A) is the most abundant internal modification of RNA in eukaryotic
cells, and, in recent years, it has gained increasing attention. A good amount of data support …

Background: Docetaxel and doxorubicin combination has been widely used in anaplastic
thyroid cancer/ATC treatment but often results in serious adverse effects and drug …

Anaplastic thyroid cancer (ATC) is a rare and lethal form of thyroid cancer that requires
urgent investigation of new molecular targets involved in its aggressive biology. In this …